Arbutus Biopharma Corporation ABUS Balance Sheet

Income Statement

Quarter End	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	203.8M	195.42M	191.22M	176.82M	158.64M	144.4M	150.29M	160.04M
Total Current Assets	141.14M	151.14M	152.85M	158.8M	141.61M	132.03M	135.87M	148.22M
Cash and Equivalents	24M	30.78M	40.57M	27.2M	17.53M	26.29M	43.1M	62.79M
Total Non-Current Assets	66.09M	47.61M	41.56M	21.81M	22.07M	15.63M	17.51M	14.65M
Total Liabilities	58.28M	58.57M	47.31M	42.13M	39.3M	38.38M	35.65M	37.59M
Total Current Liabilities	27.51M	32.86M	25.15M	24.53M	22.32M	22.49M	20.3M	22.6M
Total Non-Current Liabilities	32.73M	25.71M	23.83M	19.25M	16.98M	15.9M	15.36M	16.14M
Common Equity	1.31B	1.32B	1.34B	1.34B	1.35B	1.35B	1.38B	1.4B
Retained Earnings	-1.18B	-1.2B	-1.22B	-1.24B	-1.26B	-1.28B	-48.37M	-1.31B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	275.92M	237.16M	227.91M	105.54M	137.08M	204.49M	195.42M	144.4M
Total Current Assets	132.56M	129.37M	129.23M	93.83M	127.7M	160.66M	151.14M	132.03M
Cash and Equivalents	23.41M	54.29M	36.94M	31.8M	52.25M	109.28M	30.78M	26.29M
Total Non-Current Assets	203.01M	182.47M	200.23M	72.74M	101.97M	169.44M	136.85M	106.02M
Total Liabilities	72.91M	54.69M	27.67M	32.79M	35.11M	35.05M	58.57M	38.38M
Total Current Liabilities	10.59M	14.63M	11.24M	7.83M	9.54M	11.22M	32.86M	22.49M
Total Non-Current Liabilities	74.33M	52.06M	16.43M	27.98M	28.17M	26.06M	25.71M	15.9M
Total Equity	203.01M	182.47M	200.23M	72.74M	101.97M	169.44M	136.85M	106.02M
Common Equity	867.39M	925.89M	1.01B	1.04B	1.14B	1.29B	1.32B	1.35B
Retained Earnings	-651.15M	-738.07M	-805.22M	-970.09M	-1.05B	-1.13B	-1.2B	-1.28B